Skip to main content

Table 3 Treatment modalities in young breast cancer patients (N = 144) and their associations with disease progression (HR hazard ratio, CI confidence interval)

From: Pathological profiles and clinical management challenges of breast cancer emerging in young women in Indonesia: a hospital-based study

Treatment modalities

N

%

HR (95%CI)

Surgery

 Palliative

16

11.10%

2.915 (0.775–10.965)

 Radical

121

84%

ref

 Conservative

7

4.90%

Chemotherapy

 Neoadjuvant

6

4.20%

1.667 (0.310–8.976)

 Adjuvant

98

68%

 Palliative

23

16%

 No

26

11.80%

ref

Radiotherapy

 No

29

20.10%

0.836 (0.321–2.1770

 Waiting list

13

9%

 Yes

102

70.80%

ref

Hormonal therapy

 Yes

49

34%

ref

 No

8

5.60%

1.04 (0.49–2.207)

 HR-negative

86

59.700%

Anti-HER2 therapy

 HER2 positive

44

30.60%

 

 No

26

18.10%

0.844 (0.203–3.504)

 Yes

18

12.50%

ref

Bisphosphonate treatment

 Yes

17

11.80%

N/A

 No

6

4.20%

N/A

 Bone metastases

23

16%

Â